Skip to content

Beta Blocker Effects in Traumatic Brain Injury

Beta Blocker Effects on Patients With Traumatic Brain Injury

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05195996
Enrollment
40
Registered
2022-01-19
Start date
2021-10-01
Completion date
2022-05-31
Last updated
2023-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma, Brain

Brief summary

The study will be conducted on polytrauma patient who are admitted from emergency room or postoperative with head trauma to evaluate effects of beta blocker on patients with TBI.

Detailed description

The study will be conducted on polytrauma patient who are admitted from emergency room or postoperative with head trauma . Patients will be randomly assigned into two groups by sealed envelope technique into two equal groups. Parameters assessment: * Length of ICU stay * Length of total hospital stay * CT scan to exclude another intracranial hemorrhage or increase in hemorrhage * Functional status will be assessed using the GCS * Hemodynamic data ( bl.p / hr ) * Crystalloid volume that patient need in 24h * Mortality rate

Interventions

DRUGPropranolol

intravenous propranolol for case patients

DRUGSaline

intravenous saline for placebo

Sponsors

Menoufia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* GCS preoperative \>10 * Abbreviated Injury Scale (AIS) \>3 * Length stay in ICU \>48 h

Exclusion criteria

* Hypersensitivity to propranolol * Asthmatic patient * COPD * History of smoking * Any cardiac problems eg: ( heart failure or HB ) * pheochromocytoma * Pregnant patient * Length stay \<48h * Death within 48 h of admission * Patient who previously received any beta blocker at home. * Symptomatic Bradycardia \<60 b/m (sick sinus syndrome) * Hemodynamic unstable patients

Design outcomes

Primary

MeasureTime frameDescription
survival7 daysnumber of surviving in patients receiving propranolol and patients who did not receive any beta blocker

Secondary

MeasureTime frameDescription
heart rate7 daysnumber of patient showing effect of beta blocker on TBI related to HR
icu stay7 daysnumber of patients were beta blocker in TBI affected on ICU and total hospital stay

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026